IBIO CIK: 1420720

iBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
45.1
FY23:
26.3
FY24:
15.7
FY25:
9.72
FY26:
92.2
(positive)
Change from FY22 to FY26
millions USD
FY22:
54.3
FY23:
14.9
FY24:
13.1
FY25:
13.5
FY26:
6.89
Total assets
Change from FY22 to FY26
millions USD
FY22:
99.4
FY23:
41.2
FY24:
28.7
FY25:
23.2
FY26:
99.1

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
30.4
FY23:
22.1
FY24:
3.84
FY25:
6.11
FY26:
11.7
(negative)
Change from FY22 to FY26
millions USD
FY22:
5.49
FY23:
3.72
FY24:
3.57
FY25:
2.20
FY26:
1.65
(positive)
Change from FY22 to FY26
millions USD
FY22:
63.5
FY23:
15.4
FY24:
21.3
FY25:
14.9
FY26:
85.7
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
99.4
FY23:
41.2
FY24:
28.7
FY25:
23.2
FY26:
99.1

All amounts in millions USD Data source:SEC EDGAR